IPI-926 Extension Protocol for Continuation of Treatment With IPI-926

NCT01609179 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Basal Cell Carcinoma
Chondrosarcoma

Interventions

DRUG: IPI-926

Sponsor

Infinity Pharmaceuticals, Inc.